These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 18098283)
1. The molecular etiology of breast cancer: evidence from biomarkers of risk. Gaikwad NW; Yang L; Muti P; Meza JL; Pruthi S; Ingle JN; Rogan EG; Cavalieri EL Int J Cancer; 2008 May; 122(9):1949-57. PubMed ID: 18098283 [TBL] [Abstract][Full Text] [Related]
2. Novel biomarkers for risk of prostate cancer: results from a case-control study. Yang L; Gaikwad NW; Meza J; Cavalieri EL; Muti P; Trock B; Rogan EG Prostate; 2009 Jan; 69(1):41-8. PubMed ID: 18816637 [TBL] [Abstract][Full Text] [Related]
3. Urine biomarkers of risk in the molecular etiology of breast cancer. Gaikwad NW; Yang L; Pruthi S; Ingle JN; Sandhu N; Rogan EG; Cavalieri EL Breast Cancer (Auckl); 2009 Jan; 3():1-8. PubMed ID: 21556245 [TBL] [Abstract][Full Text] [Related]
4. The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Cavalieri E; Rogan E Mol Aspects Med; 2014 Apr; 36():1-55. PubMed ID: 23994691 [TBL] [Abstract][Full Text] [Related]
5. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129 [TBL] [Abstract][Full Text] [Related]
6. Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma. Gaikwad NW; Yang L; Weisenburger DD; Vose J; Beseler C; Rogan EG; Cavalieri EL Biomarkers; 2009 Nov; 14(7):502-12. PubMed ID: 19863189 [TBL] [Abstract][Full Text] [Related]
7. Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease. Cavalieri EL; Rogan EG; Zahid M Int J Cancer; 2017 Sep; 141(6):1078-1090. PubMed ID: 28388839 [TBL] [Abstract][Full Text] [Related]
8. Unbalanced estrogen metabolism in thyroid cancer. Zahid M; Goldner W; Beseler CL; Rogan EG; Cavalieri EL Int J Cancer; 2013 Dec; 133(11):2642-9. PubMed ID: 23686454 [TBL] [Abstract][Full Text] [Related]
9. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897 [TBL] [Abstract][Full Text] [Related]
10. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Cavalieri E; Rogan E Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777 [TBL] [Abstract][Full Text] [Related]
11. Unbalanced estrogen metabolism in ovarian cancer. Zahid M; Beseler CL; Hall JB; LeVan T; Cavalieri EL; Rogan EG Int J Cancer; 2014 May; 134(10):2414-23. PubMed ID: 24170413 [TBL] [Abstract][Full Text] [Related]
12. Etiology and prevention of prevalent types of cancer. Cavalieri EL; Rogan EG J Rare Dis Res Treat; 2017; 2(3):22-29. PubMed ID: 30854528 [TBL] [Abstract][Full Text] [Related]
13. Estrogen Metabolism in African-American Women with and without Breast Cancer: A Pilot Study. Zahid M; Mondal B; LeVan TD; Rogan EG Chem Res Toxicol; 2019 Jan; 32(1):190-194. PubMed ID: 30525503 [TBL] [Abstract][Full Text] [Related]
14. Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Cavalieri EL; Rogan EG Future Oncol; 2010 Jan; 6(1):75-91. PubMed ID: 20021210 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review. Yager JD Steroids; 2015 Jul; 99(Pt A):56-60. PubMed ID: 25159108 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of depurinating estrogen-DNA adduct formation by natural compounds. Zahid M; Gaikwad NW; Rogan EG; Cavalieri EL Chem Res Toxicol; 2007 Dec; 20(12):1947-53. PubMed ID: 18039013 [TBL] [Abstract][Full Text] [Related]
17. Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention. Cavalieri EL; Rogan EG Clin Transl Med; 2016 Mar; 5(1):12. PubMed ID: 26979321 [TBL] [Abstract][Full Text] [Related]
18. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531 [TBL] [Abstract][Full Text] [Related]
19. Potential biomarker for early risk assessment of prostate cancer. Markushin Y; Gaikwad N; Zhang H; Kapke P; Rogan EG; Cavalieri EL; Trock BJ; Pavlovich C; Jankowiak R Prostate; 2006 Oct; 66(14):1565-71. PubMed ID: 16894534 [TBL] [Abstract][Full Text] [Related]
20. Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. Cavalieri EL; Rogan EG J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):169-80. PubMed ID: 21397019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]